SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Aug-24 4:12 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 11-Aug-24 | Option Exercise | 2,302 | -- | -- | 40% 5.69K to 7.99K | |
17-Jun-24 5:20 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Option Exercise | 3,388 | -- | -- | 147% 2.3K to 5.69K | |
10-Jun-24 4:20 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-24 | Grant | 30,000 | -- | -- | 32% 95.23K to 125.23K | |
30-May-24 4:17 PM View: | Spero Therapeutics, Inc. (SPRO) | 29-May-24 | Grant | 20,000 | -- | -- | 57% 35.0K to 55.0K | |
10-Oct-23 5:40 PM View: | Spero Therapeutics, Inc. (SPRO) | 05-Oct-23 | Grant | 20,000 | -- | -- | 133% 15.0K to 35.0K | |
15-Aug-23 4:04 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 11-Aug-23 | Option Exercise | 2,302 | -- | -- | 100% 0 to 2.3K | |
08-Jun-23 4:07 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-23 | Grant | 30,000 | -- | -- | 46% 65.23K to 95.23K | |
19-Sep-22 5:44 PM View: | Spero Therapeutics, Inc. (SPRO) | 15-Sep-22 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
09-Jun-22 4:59 PM View: | Akebia Therapeutics, Inc. (AKBA) | 08-Jun-22 | Grant | 13,700 | -- | -- | 27% 51.53K to 65.23K | |
29-Dec-21 4:21 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 3,333 | $38.25 | $127,487.00 | (100%) 3.33K to 0 | < 1% |
07-Jun-21 9:35 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 03-Jun-21 | Option Exercise | 3,333 | -- | -- | 100% 0 to 3.33K | |
03-Jun-21 5:27 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Jun-21 | Grant | 13,700 | -- | -- | 36% 37.83K to 51.53K | |
09-Jun-20 4:17 PM View: | Akebia Therapeutics, Inc. (AKBA) | 08-Jun-20 | Market Sale (Planned) | 4,567 | $12.10 | $55,260.70 | (11%) 42.4K to 37.83K | 75% |
09-Jun-20 4:17 PM View: | Akebia Therapeutics, Inc. (AKBA) | 05-Jun-20 | Grant | 13,700 | -- | -- | 48% 28.7K to 42.4K | |
22-Nov-19 6:20 AM View: | Akebia Therapeutics, Inc. (AKBA) | 20-Nov-19 | Market Purchase | 15,000 | $3.52 | $52,800.00 | 109% 13.7K to 28.7K | (14%) |
10-Jun-19 4:04 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-19 | Grant | 13,700 | -- | -- | 100% 0 to 13.7K | |
21-Dec-15 6:46 PM View: | Zs Pharma, Inc. (ZSPH) | 17-Dec-15 | Disposition | 12,598 | $90.00 | $1,133,820.00 | (100%) 12.6K to 0 | |
10-Dec-15 9:23 PM View: | Zs Pharma, Inc. (ZSPH) | 08-Dec-15 | Option Exercise | 9,155 | $10.92 | $100,011.00 | 100% 0 to 9.15K |